FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival

Summary

The FDA held a public forum on psychedelic therapeutics and a meeting on PDUFA reauthorization. Definium Therapeutics achieved a late-stage trial win for its LSD drug, while Novartis faced recent asset setbacks.